-
18448-5An aldehyde product of the oxidative deamination of dopamine that is toxic to neurons.
-
18448-50An aldehyde product of the oxidative deamination of dopamine that is toxic to neurons.
-
A0916-25 mg
Thomas Scientific
Dopamine D1/2 receptor and 5-HT1A/2A receptor antagonist used to prevent nausea and induce sedation. It also prevents sudden cardiac death in models of status epilepticus and reduces vasopressor activity of dopamine during anesthesia. (C08-0488-826)
Price: $244.12List Price: $271.25Dopamine D1/2 receptor and 5-HT1A/2A receptor antagonist use -
A0916-100 mg
Thomas Scientific
Dopamine D1/2 receptor and 5-HT1A/2A receptor antagonist used to prevent nausea and induce sedation. It also prevents sudden cardiac death in models of status epilepticus and reduces vasopressor activity of dopamine during anesthesia. (C08-0489-238)
Price: $402.76List Price: $447.51Dopamine D1/2 receptor and 5-HT1A/2A receptor antagonist use -
A0916-250 mg
Thomas Scientific
Dopamine D1/2 receptor and 5-HT1A/2A receptor antagonist used to prevent nausea and induce sedation. It also prevents sudden cardiac death in models of status epilepticus and reduces vasopressor activity of dopamine during anesthesia. (C08-0489-479)
Price: $601.37List Price: $668.19Dopamine D1/2 receptor and 5-HT1A/2A receptor antagonist use -
10460-1A highly potent inhibitor of p38 MAPK (Kd = 0.1 nM) that blocks TNF&alpha release in LPS-stimulated THP-1 cells with an IC50 value of 18 nM At 10 &muM, inhibits JNK2&alpha2 in vitro.
-
10460-10A highly potent inhibitor of p38 MAPK (Kd = 0.1 nM) that blocks TNF&alpha release in LPS-stimulated THP-1 cells with an IC50 value of 18 nM At 10 &muM, inhibits JNK2&alpha2 in vitro.
-
10460-25A highly potent inhibitor of p38 MAPK (Kd = 0.1 nM) that blocks TNF&alpha release in LPS-stimulated THP-1 cells with an IC50 value of 18 nM At 10 &muM, inhibits JNK2&alpha2 in vitro.
-
10460-5A highly potent inhibitor of p38 MAPK (Kd = 0.1 nM) that blocks TNF&alpha release in LPS-stimulated THP-1 cells with an IC50 value of 18 nM At 10 &muM, inhibits JNK2&alpha2 in vitro.
-
19467-10An anthelmintic antibiotic that at 0.001 µg/ml is fully effective at inhibiting growth in an H. contortus larval development assay.
-
19467-25An anthelmintic antibiotic that at 0.001 µg/ml is fully effective at inhibiting growth in an H. contortus larval development assay.
-
19467-5An anthelmintic antibiotic that at 0.001 µg/ml is fully effective at inhibiting growth in an H. contortus larval development assay.